Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE American:HEB)

0.3151
Delayed Data
As of 1:02pm ET
 +0.0051 / +1.65%
Today’s Change
0.30
Today|||52-Week Range
0.93
-54.32%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Equels Thomas Kenwood
President & Chief Executive Officer
Buy4/11/2017200,000$0.50$100.0K-44.64%
Equels Thomas Kenwood
President & Chief Executive Officer
Buy4/27/201772,464$0.69$50.0K-53.75%
Equels Thomas Kenwood
President & Chief Executive Officer
Buy12/22/201668,493$0.73$50.0K-55.07%
Springate Wayne S
Senior Vice President-Operations
Buy5/02/201715,873$0.63$10.0K-53.59%
Rodino Peter W Iii
Buy5/02/201715,873$0.63$10.0K-53.59%
Pascale Adam
Chief Financial Officer
Buy5/02/201715,873$0.63$10.0K-53.59%
Strayer David R
Buy5/02/20177,937$0.63$5.0K-53.59%
Strayer David R
Buy2/16/20179,892$0.46$4.6K-32.61%
Springate Wayne S
Senior Vice President-Operations
Buy2/16/20178,014$0.46$3.7K-32.61%
Pascale Adam
Chief Financial Officer
Buy2/16/20176,981$0.46$3.2K-32.61%